News from the Nucleic Acid Chemistry Center at UMass Chan Medical School

UMass Chan licenses potential RNA-based treatment for fragile X syndrome to QurAlis Corporation.

A siRNA therapeutic for dermatological diseases developed at UMass Chan Medical School has entered the clinical trial phase.

This special edition of @umasschan magazine celebrates Victor Ambros, PhD, the newest Nobel laureate at UMass Chan Medical School.

Anastasia Khvorova, PhD, has been awarded the 2025 Else Kröner Fresenius Prize for Medical Research.

UMass Chan supports translational research from faculty with internal funding mechanism.

A roundtable panel, led by Rep. McGovern and Dean Flotte, discussed the immediate impacts of potential cuts to NIH funding.

PhD candidate Jesse Lehman has received a Ruth L. Kirschstein grant for mRNA immunology research.

PhD candidate Alejandro Félix Mejía has received a Ruth L. Kirschstein grant for mRNA research.

Top story: UMass Chan Medical School researcher Victor R. Ambros, PhD, will share the 2024 Nobel Prize in Physiology or Medicine for his co-discovery of microRNA, the very short, single-stranded RNA molecules that are now understood to play a critical role in post-transcriptional gene regulation.

Victor R. Ambros, PhD, was awarded the Nobel Prize in Physiology or Medicine on Tuesday, Dec. 10 in Stockholm, Sweden.